Scinai Immunotherapeutics (SCNI) Earnings Date & Reports

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

SCNI is expected to report earnings to fall 3,548.28% to -10 cents per share on May 02

Scinai Immunotherapeutics SCNI Stock Earnings Reports

Q4'22

Est.

$-0.10

Q3'22

Beat

by $0.10

Q2'22

Est.

$-0.01

Q1'22

Est.

$0.00

The last earnings report on November 30 showed earnings per share of 0 cents, beating the estimate of -10 cents. With 2.10K shares outstanding, the current market capitalization sits at 2.66M.

View a ticker or compare two or three

Compare

SCNI